Intravitreal aflibercept alone versus combination with dexamethasone phosphate for diabetic macular edema: A randomized phase-2 clinical trial

Valesca Castro Neri¹; Rodrigo Pessoa Cavalcanti Lira¹; Andrea Andrade Azevedo de Vasconcelos¹; Pedro Henrique Lasalvia Jorge¹; Gabriel Rocha Lira¹; Victor da Cunha Lima Almeida¹

DOI: 10.5935/0004-2749.2024-0098

Universidade Federal de Pernambuco, Recife, PE, Brazil

Corresponding author

Rodrigo Pessoa Cavalcanti Lira
E-mail: [email protected]

Funding: This study received no specific financial support.

Disclosure of potential conflicts of interest: The authors declare no potential conflicts of interest.

Print PDF English

How to cite this article:

Neri VC, Lira RPC, Vasconcelos AAA, Jorge PHL, Lira GR, Almeida VCL. Intravitreal aflibercept alone versus combination with dexamethasone phosphate for diabetic macular edema: A randomized phase-2 clinical trial. Arq. Bras. Oftalmol. 2025;88(5):. 10.5935/0004-2749.2024-0098

Export citation